Oral Formulation of Insulin for Preterm Infants

NCT01093638 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Premature Birth of Newborn

Interventions

BIOLOGICAL: Oral Formulation of Insulin
BIOLOGICAL: Placebo

Sponsor

Elgan Pharma Ltd.